106 related articles for article (PubMed ID: 35017106)
1. Characteristics analysis for clinical study design relating to COVID-19 based on the database of ClinicalTrials.gov.
Wu H; Dai R; He P; Liang J; Li Q; Yang J; Lu H; Guo Q; Mao W; Ji C
Int J Infect Dis; 2022 Mar; 116():210-215. PubMed ID: 35017106
[TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of Clinical Trials relating to COVID-19 registered at ClinicalTrials.gov.
Wang Y; Zhou Q; Xu M; Kang J; Chen Y
J Clin Pharm Ther; 2020 Dec; 45(6):1357-1362. PubMed ID: 32734670
[TBL] [Abstract][Full Text] [Related]
4. The Landscape of COVID-19 Research in the United States: a Cross-sectional Study of Randomized Trials Registered on ClinicalTrials.Gov.
Sacks CA; North CM; Wolf M; Dougan M; Campbell KR; Moggridge J; Fralick M
J Gen Intern Med; 2022 Jan; 37(1):154-161. PubMed ID: 34755268
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis.
Mehta HB; Ehrhardt S; Moore TJ; Segal JB; Alexander GC
BMJ Open; 2020 Jun; 10(6):e039978. PubMed ID: 32518212
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Trends in the Design, Accrual, and Completion of Trials Registered in ClinicalTrials.gov by Sponsor Type, 2000-2019.
Gresham G; Meinert JL; Gresham AG; Meinert CL
JAMA Netw Open; 2020 Aug; 3(8):e2014682. PubMed ID: 32845329
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of academic publications, preprints, and registered clinical trials on the COVID-19 pandemic.
Gianola S; Jesus TS; Bargeri S; Castellini G
PLoS One; 2020; 15(10):e0240123. PubMed ID: 33022014
[TBL] [Abstract][Full Text] [Related]
8. Chemoprophylaxis trial designs in epidemics: insights from a systematic review of COVID-19 study registrations.
Manoharan L; Olliaro P; Horby PW; Watson CH
Trials; 2021 May; 22(1):370. PubMed ID: 34051840
[TBL] [Abstract][Full Text] [Related]
9. Current landscape of type 1 diabetes mellitus-related interventional clinical trials registered on ClinicalTrials.gov: a cross-sectional study.
Liang R; Long J; Zheng Q; Yuan G; Chen X; Xin Z; Lai F; Liu Y
Acta Diabetol; 2021 Jun; 58(6):723-733. PubMed ID: 33543370
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
11. A large number of COVID-19 interventional clinical trials were registered soon after the pandemic onset: a descriptive analysis.
Nasrallah AA; Farran SH; Nasrallah ZA; Chahrour MA; Salhab HA; Fares MY; Khachfe HH; Akl EA
J Clin Epidemiol; 2020 Sep; 125():170-178. PubMed ID: 32526460
[TBL] [Abstract][Full Text] [Related]
12. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
[TBL] [Abstract][Full Text] [Related]
14. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF
Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473
[TBL] [Abstract][Full Text] [Related]
15. Ongoing non-industry-sponsored COVID-19 clinical trials in the first trimester of the pandemic: significant differences between the European and the USA approaches.
Dal-Ré R
Expert Rev Clin Pharmacol; 2020 Sep; 13(9):1067-1072. PubMed ID: 32795214
[TBL] [Abstract][Full Text] [Related]
16. Suspension of Oncology Randomized Clinical Trials during the COVID-19 Pandemic: A Cross-Sectional Evaluation of COVID-Related Suspensions.
Sayyid RK; Hiffa A; Woodruff P; Oberle MD; Lambert JH; Terris MK; Wallis CJD; Klaassen Z
Cancer Invest; 2022 Oct; 40(9):743-749. PubMed ID: 35852930
[TBL] [Abstract][Full Text] [Related]
17. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
[TBL] [Abstract][Full Text] [Related]
18. The Impact of COVID-19 on the Conduct of Clinical Trials for Medical Products in Korea.
Jeon J; Kim H; Yu KS
J Korean Med Sci; 2020 Sep; 35(36):e329. PubMed ID: 32924344
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010.
Califf RM; Zarin DA; Kramer JM; Sherman RE; Aberle LH; Tasneem A
JAMA; 2012 May; 307(17):1838-47. PubMed ID: 22550198
[TBL] [Abstract][Full Text] [Related]
20. Implications of the lack of a unified research project framework: an investigation into the registration of clinical trials of COVID-19.
Wang B; Lai J; Yan X; Jin F; Yao C
Curr Med Res Opin; 2020 Jul; 36(7):1131-1135. PubMed ID: 32427000
[No Abstract] [Full Text] [Related]
[Next] [New Search]
